title: Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.
authors.affiliation: Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Nakano
authors.affiliation: Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: L
authors.initials: L
authors.lastname: Inagaki
authors.affiliation: Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Tomomatsu
authors.affiliation: The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Motoi
authors.affiliation: Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Gokita
authors.affiliation: Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Ae
authors.affiliation: Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Tanizawa
authors.affiliation: Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Shimoji
authors.affiliation: Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Matsumoto
authors.affiliation: Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Takahashi
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D007191:Indazoles; D008297:Male; D008875:Middle Aged; D011030:Pneumothorax / Q000139:chemically induced* / Q000453:epidemiology; D011743:Pyrimidines / Q000009:adverse effects*; D012189:Retrospective Studies; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D020533:Angiogenesis Inhibitors; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib